跳至主要内容
临床试验/EUCTR2012-001886-33-FI
EUCTR2012-001886-33-FI进行中(未招募)不适用

Randomized, Controlled, Parallel Group, Double Blind Trial to Compare the Use of Deep or Standard Neuromuscular Blockade in Combination With Low or Standard Insufflation Pressures Using a 2x2 Factorial Design in Patients Undergoing Laparoscopic Cholecystectomy (Protocol No. MK-8616-076-00 also known as SCH 900616, P07982) - Effects of Depth of Neuromuscular Blockade and Insufflation Pressure on Surgical Conditions

Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.0 个研究点目标入组 120 人开始时间: 2012年10月15日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Subjects must be: Males/Females = 18 yrs; ASA (American Society of Anesthesiologists) Class 1, 2 or 3; scheduled for laparoscopic cholecystectomy (standard 4-hole) procedure under general anesthesia with total intravenous anesthesia (TIVA) using propofol and remifentanil and is expected to undergo rocuronium-induced neuromuscular blockade for endotracheal intubation and require active reversal of neuromuscular blockade.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 120
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range 0

排除标准

  • Subjects with neuromuscular disorders that may affect neuromuscular blockade and/or assessments will be excluded from this study, in addition subjects who cannot meeting general standards for anesthesia trials (inability to intubate, renal/hepatic dysfunction, allergies to general anesthesia medications, malignant hyperthermia, interactions with toremifene/fusidic acid, pregnant patients, previous enrollment in trials or relation to staff) will also be excluded.

研究者

相似试验

进行中(未招募)
1 期
Effects of Depth of Neuromuscular Blockade and Insufflation Pressure on Surgical Conditions.Patients undergoing elective in-patient laparoscopic cholecystectomy procedures under general anesthesia with neuromuscular relaxation and active reversal of neuromuscular blockade.MedDRA version: 14.1 Level: LLT Classification code 10018061 Term: General anesthesia System Organ Class: 100000004865
EUCTR2012-001886-33-ITMerck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.127
进行中(未招募)
不适用
Effects of Depth of Neuromuscular Blockade and Insufflation Pressure on Surgical Conditions
EUCTR2012-001886-33-ATMerck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.120
进行中(未招募)
不适用
Effects of Depth of Neuromuscular Blockade and Insufflation Pressure on Surgical ConditionsPatients undergoing elective in-patient laparoscopic cholecystectomy procedures under general anesthesia with neuromuscular relaxation and active reversal of neuromuscular blockadeMedDRA version: 16.1Level: LLTClassification code 10018061Term: General anesthesiaSystem Organ Class: 100000004865
EUCTR2012-001886-33-DEMerck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.120
进行中(未招募)
1 期
Effects of Depth of Neuromuscular Blockade and Insufflation Pressure on Surgical Conditions
EUCTR2012-001886-33-GBMerck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.127
已完成
不适用
Randomized, Double Blind, Parallel Group, Controlled with Placebo Study performed Under Internal Blind Conditions whose Purpose is to Examine the Safety, Tolerability and Efficacy of MK-0869 for the Prevention of Nausea and Vomiting Induced by Chemotherapy Associated with Administration of High doses of Cisplatin.-C80 Malignant neoplasm, without specification of siteMalignant neoplasm, without specification of siteC80
PER-009-01MERCK SHARP & DOHME PERU S.R.L.,